How many years does rasagiline last?

Rasagiline is an effective drug for the treatment of Parkinson's disease. Its effects usually last for several years, but the specific duration of effectiveness varies between individuals.

As a monoamine oxidase inhibitor, rasagiline's main function is to inhibit the degradation of dopamine, thereby increasing the concentration of dopamine in the brain. This mechanism of action makes rasagiline's efficacy relatively long-lasting. In clinical trials, rasagiline has been shown to consistently improve symptoms in patients with Parkinson's disease, often for years.

While rasagiline is effective for most people with Parkinson's disease, each person's response and duration may vary. Some patients may feel significant effects of the drug within a shorter period of time, while others may take longer to see results. In addition, factors such as the patient's age, severity of illness, and comorbidities may also affect the efficacy and duration of the drug.

For patients who require long-term use of rasagiline, it is very important to regularly monitor drug efficacy and adjust the treatment plan. Over time, patients may develop a tolerance to the medication, or their condition may change, requiring medication dosage adjustments or substitutions to maintain efficacy.

According to data from multiple clinical studies, rasagiline has shown significant efficacy in the treatment of Parkinson's disease, and this efficacy can be maintained for several years. For example, in some long-term follow-up studies, patients taking rasagiline maintained better symptom control and quality of life for several years.